GENSIGHT BIOLOGICS Stock Bullish By 17% So Far Today
GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA), a clinical-stage biotechnology firm, surged by 17.36% today to hit EUR0.48 at 11:52 EST on Friday. This marked an end to five consecutive days of losses, recovering after three sessions in which France’s benchmark CAC 40 index experienced declines. GenSight Biologics: Innovative Therapies GenSight Biologics has become known for its…